| 1 |
2022 |
Olivia L. Walker, Margaret L. Dahn, Melanie R. Power Coombs, Paola Marcato. The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting, Frontiers in Oncology. 2022; 11: 791696.
https://doi.org/10.3389/fonc.2021.791696 |
| 2 |
2021 |
Weixuan Wang, Changmei Yang, Haiteng Deng. Overexpression of 15-Hydroxyprostaglandin Dehydrogenase Inhibits A549 Lung Adenocarcinoma Cell Growth via Inducing Cell Cycle Arrest and Inhibiting Epithelial-Mesenchymal Transition, Cancer Management and Research. 2021; Volume 13: 8887.
https://doi.org/10.2147/CMAR.S331222 |
| 3 |
2024 |
Milan Teraiya, Oleg Krokhin, Vincent C. Chen, Hélène Perreault. Cytoplasmic Shotgun Proteomic Points to Key Proteins and Pathways in Temozolomide-Resistant Glioblastoma Multiforme, Journal of Proteome Research. 2024; 23: 465.
https://doi.org/10.1021/acs.jproteome.3c00669 |
| 4 |
2025 |
SubbaRao V. Tulimilli, Medha Karnik, Anjali Devi S. Bettadapura, Olga A. Sukocheva, Edmund Tse, Gowthamarajan Kuppusamy, Suma M. Natraj, SubbaRao V. Madhunapantula. The tumor suppressor role and epigenetic regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in cancer and tumor microenvironment (TME), Pharmacology & Therapeutics. 2025; 108826108826.
https://doi.org/10.1016/j.pharmthera.2025.108826 |
| 5 |
2022 |
Yunfei Xu, Haoduo Qiao, Shun Yang, Lin Zhou, Yao Zhao, Qing Xu, Shuying Miao, Dun Yuan, Jie Zhao, Ying Liu. 15-Hydroxyprostaglandin Dehydrogenase Is a Predictor of Stroke-Associated Pneumonia, Frontiers in Neurology. 2022; 13: 893624.
https://doi.org/10.3389/fneur.2022.893624 |
